1,051
Views
0
CrossRef citations to date
0
Altmetric
Hemodialysis and Peritoneal Dialysis

Association of frequent intradialytic hypotension with the clinical outcomes of patients on hemodialysis: a prospective cohort study

, , , , &
Article: 2296612 | Received 19 May 2023, Accepted 12 Dec 2023, Published online: 04 Jan 2024

References

  • Saran R, Robinson B, Abbott KC, et al. US renal data system 2018 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2019;73(3 Suppl 1):1–10. doi:10.1053/j.ajkd.2019.01.001.
  • Suri RS, Larive B, Sherer S, et al. Risk of vascular access complications with frequent hemodialysis. J Am Soc Nephrol. 2013;24(3):498–505. doi:10.1681/ASN.2012060595.
  • Kanbay M, Ertuglu LA, Afsar B, et al. An update review of intradialytic hypotension: concept, risk factors, clinical implications and management. Clin Kidney J. 2020;13(6):981–993. doi:10.1093/ckj/sfaa078.
  • Leypoldt JK, Cheung AK, Delmez JA, et al. Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int. 2002;61(1):266–275. doi:10.1046/j.1523-1755.2002.00099.x.
  • Davenport A. Why is intradialytic hypotension the commonest complication of outpatient dialysis treatments? Kidney Int Rep. 2023;8(3):405–418. doi:10.1016/j.ekir.2022.10.031.
  • Shoji T, Tsubakihara Y, Fujii M, et al. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int. 2004;66(3):1212–1220. doi:10.1111/j.1523-1755.2004.00812.x.
  • Stefánsson BV, Brunelli SM, Cabrera C, et al. Intradialytic hypotension and risk of cardiovascular disease. Clin J Am Soc Nephrol. 2014;9(12):2124–2132. doi:10.2215/CJN.02680314.
  • Chang TI, Paik J, Greene T, et al. Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol. 2011;22(8):1526–1533. doi:10.1681/ASN.2010101119.
  • Matsuura R, Hidaka S, Ohtake T, et al. Intradialytic hypotension is an important risk factor for critical limb ischemia in patients on hemodialysis. BMC Nephrol. 2019;20(1):473. doi:10.1186/s12882-019-1662-x.
  • Breidthardt T, McIntyre CW. Dialysis-induced myocardial stunning: the other side of the cardiorenal syndrome. Rev Cardiovasc Med. 2011;12(1):13–20. doi:10.3909/ricm0585.
  • Correa S, Pena-Esparragoza JK, Scovner KM, et al. Predictors of intradialytic symptoms: an analysis of data from the hemodialysis study. Am J Kidney Dis. 2020;76(3):331–339. doi:10.1053/j.ajkd.2020.01.004.
  • Morfin JA, Fluck RJ, Weinhandl ED, et al. Intensive hemodialysis and treatment complications and tolerability. Am J Kidney Dis. 2016;68(5S1):S43–S50. doi:10.1053/j.ajkd.2016.05.021.
  • Wang J, Yao J, Zhu X, et al. Impact of frequent intradialytic hypotension on quality of life in patients undergoing hemodialysis. BMC Nephrol. 2023;24(1):209. doi:10.1186/s12882-023-03263-6.
  • Reeves PB, Mc Causland FR. Mechanisms, clinical implications, and treatment of intradialytic hypotension. Clin J Am Soc Nephrol. 2018;13(8):1297–1303. doi:10.2215/CJN.12141017.
  • Sands JJ, Usvyat LA, Sullivan T, et al. Intradialytic hypotension: frequency, sources of variation and correlation with clinical outcome. Hemodial Int. 2014;18(2):415–422. doi:10.1111/hdi.12138.
  • Rocha A, Sousa C, Teles P, et al. Effect of dialysis day on intradialytic hypotension risk. Kidney Blood Press Res. 2016;41(2):168–174. doi:10.1159/000443418.
  • Hussein WF, Schiller B. Dialysate sodium and intradialytic hypotension. Semin Dial. 2017;30(6):492–500. doi:10.1111/sdi.12634.
  • Larkin JW, Reviriego-Mendoza MM, Usvyat LA, et al. To cool, or too cool: is reducing dialysate temperature the optimal approach to preventing intradialytic hypotension? Semin Dial. 2017;30(6):501–508. doi:10.1111/sdi.12628.
  • Odudu A, Eldehni MT, McCann GP, et al. Randomized controlled trial of individualized dialysate cooling for cardiac protection in hemodialysis patients. Clin J Am Soc Nephrol. 2015;10(8):1408–1417. doi:10.2215/CJN.00200115.
  • Mustafa RA, Bdair F, Akl EA, et al. Effect of lowering the dialysate temperature in chronic hemodialysis: a systematic review and Meta-Analysis. Clin J Am Soc Nephrol. 2016;11(3):442–457. doi:10.2215/CJN.04580415.
  • Vareesangthip K, Davenport A. Reducing the risk of intradialytic hypotension by altering the composition of the dialysate. Hemodial Int. 2020;24(3):276–281. doi:10.1111/hdi.12840.
  • Nesrallah GE, Suri RS, Thiessen-Philbrook H, et al. Can extracellular fluid volume expansion in hemodialysis patients be safely reduced using the hemocontrol biofeedback algorithm? A randomized trial. Asaio J. 2008;54(3):270–274. doi:10.1097/MAT.0b013e318169271e.
  • Kuipers J, Verboom LM, Ipema KJR, et al. The prevalence of intradialytic hypotension in patients on conventional hemodialysis: a systematic review with Meta-Analysis. Am J Nephrol. 2019;49(6):497–506. doi:10.1159/000500877.
  • Flythe JE, Xue H, Lynch KE, et al. Association of mortality risk with various definitions of intradialytic hypotension. J Am Soc Nephrol. 2015;26(3):724–734. doi:10.1681/ASN.2014020222.
  • Workgroup KD. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):S1–S153.
  • Kooman J, Basci A, Pizzarelli F, et al. EBPG guideline on haemodynamic instability. Nephrol Dial Transplant. 2007;22 Suppl 2:ii22–44. doi:10.1093/ndt/gfm019.
  • Assimon MM, Flythe JE. Definitions of intradialytic hypotension. Semin Dial. 2017;30(6):464–472. doi:10.1111/sdi.12626.
  • Vascular access for hemodialysis consensus (version 2). Chinese Journal of Blood Purification. 2019;18:365–381.
  • Daugirdas JT. Second generation logarithmic estimates of single-Pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993;4(5):1205–1213. doi:10.1681/ASN.V451205.
  • Luo H, Yang H, Huang B, et al. Geriatric nutritional risk index (GNRI) independently predicts amputation inchronic criticallimb ischemia (CLI). PLoS One. 2016;11(3):e0152111. doi:10.1371/journal.pone.0152111.
  • Tsai MT, Tseng WC, Ou SM, et al. Comparison of simplified creatinine index and systemic inflammatory markers for nutritional evaluation of hemodialysis patients. Nutrients. 2021;13(6):1870. doi:10.3390/nu13061870.
  • Daugirdas JT. Measuring intradialytic hypotension to improve quality of care. J Am Soc Nephrol. 2015;26(3):512–514. doi:10.1681/ASN.2014090860.
  • Meredith DJ, Pugh CW, Sutherland S, et al. The relationship between symptoms and blood pressure during maintenance hemodialysis. Hemodial Int. 2015;19(4):543–552. doi:10.1111/hdi.12306.
  • Agarwal R. B-type natriuretic peptide is not a volume marker among patients on hemodialysis. Nephrol Dial Transplant. 2013;28(12):3082–3089. doi:10.1093/ndt/gft054.
  • Mallamaci F, Zoccali C, Tripepi G, et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int. 2001;59(4):1559–1566. doi:10.1046/j.1523-1755.2001.0590041559.x.
  • Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol. 2001;12(7):1508–1515. doi:10.1681/ASN.V1271508.
  • Chen CH, Lin YP, Yu WC, et al. Volume status and blood pressure during long-term hemodialysis: role of ventricular stiffness. Hypertension. 2003;42(3):257–262. doi:10.1161/01.HYP.0000085857.95253.79.
  • Burton JO, Jefferies HJ, Selby NM, et al. Hemo­dialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol. 2009;4(5):914–920. doi:10.2215/CJN.03900808.
  • Ma L, Zhao S. Risk factors for mortality in patients undergoing hemodialysis: a systematic review and meta-analysis. Int J Cardiol. 2017;238:151–158. doi:10.1016/j.ijcard.2017.02.095.
  • Kawaguchi T, Tong L, Robinson BM, et al. C-reactive protein and mortality in hemodialysis patients: the dialysis outcomes and practice patterns study (DOPPS). Nephron Clin Pract. 2011;117(2):c167–178. doi:10.1159/000320116.
  • Roy-Chaudhury P, Spergel LM, Besarab A, et al. Biology of arteriovenous fistula failure. J Nephrol. 2007;20(2):150–163.
  • You L, Wu Y, Zheng Y, et al. Elevated serum interleukin-18 level is correlated with vascular access dysfunction in patients on maintenance haemodialysis. Ann Acad Med Singap. 2020;49(3):119–126. doi:10.47102/annals-acadmedsg.2019239.
  • Wu Y, Wang F, Wang T, et al. Association of Retinol-Binding protein 4 with arteriovenous fistula dysfunction in hemodialysis patients. Blood Purif. 2021;50(6):906–913. doi:10.1159/000513418.